ABMD
Price:
$381.02
Market Cap:
$17.18B
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flo...[Read more]
Industry
Medical - Devices
IPO Date
1987-07-29
Stock Exchange
NASDAQ
Ticker
ABMD
According to Abiomed, Inc.’s latest financial reports and current stock price. The company's current ROE is 9.64%. This represents a change of 118.40% compared to the average of 4.41% of the last 4 quarters.
The mean historical ROE of Abiomed, Inc. over the last ten years is 16.52%. The current 9.64% ROE has changed -41.66% with respect to the historical average. Over the past ten years (40 quarters), ABMD's ROE was at its highest in in the March 2015 quarter at 33.91%. The ROE was at its lowest in in the June 2021 quarter at -2.03%.
Average
16.52%
Median
13.90%
Minimum
4.37%
Maximum
38.99%
Discovering the peaks and valleys of Abiomed, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 825.28%
Maximum Annual ROE = 38.99%
Minimum Annual Increase = -73.47%
Minimum Annual ROE = 4.37%
Year | ROE | Change |
---|---|---|
2022 | 9.08% | -46.46% |
2021 | 16.96% | -10.98% |
2020 | 19.05% | -31.08% |
2019 | 27.65% | 69.95% |
2018 | 16.27% | 41.11% |
2017 | 11.53% | 11.45% |
2016 | 10.34% | -73.47% |
2015 | 38.99% | 793.02% |
2014 | 4.37% | -60.13% |
2013 | 10.95% | 825.28% |
The current ROE of Abiomed, Inc. (ABMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.03%
5-year avg
17.80%
10-year avg
16.52%
Abiomed, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abiomed, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abiomed, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Abiomed, Inc.'s ROE?
How is the ROE calculated for Abiomed, Inc. (ABMD)?
What is the highest ROE for Abiomed, Inc. (ABMD)?
What is the 3-year average ROE for Abiomed, Inc. (ABMD)?
What is the 5-year average ROE for Abiomed, Inc. (ABMD)?
How does the current ROE for Abiomed, Inc. (ABMD) compare to its historical average?